<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-21T23:56:45+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2714】COMMF市场及销售分论坛｜圆桌讨论精要（一）</title>
    <updated>2021-01-21T19:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/L6V2cNIvRLEQWIk4TnJMoQ</id>
    <link href="https://mp.weixin.qq.com/s/L6V2cNIvRLEQWIk4TnJMoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2021 ASCO-GI】曾江正教授对话林海锋教授：安罗替尼联合特瑞普利单抗一线治疗不可切除肝癌潜力巨大</title>
    <updated>2021-01-21T19:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/wSVZnmyl-Po6irO9l5x7lQ</id>
    <link href="https://mp.weixin.qq.com/s/wSVZnmyl-Po6irO9l5x7lQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【年度巨制】2020肺癌年终盘点Session 2：驱动基因阳性Ⅳ期NSCLC之EGFR突变一线治疗研究进展</title>
    <updated>2021-01-21T19:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/8advB7Nu--_xRIDrQoN_nw</id>
    <link href="https://mp.weixin.qq.com/s/8advB7Nu--_xRIDrQoN_nw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张翼鷟教授：儿童肿瘤药物临床研究现状与中肿实践</title>
    <updated>2021-01-21T19:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/1Gw8B3Bv6vTme-Opbs5kEw</id>
    <link href="https://mp.weixin.qq.com/s/1Gw8B3Bv6vTme-Opbs5kEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>张苏展教授：结直肠癌三线治疗再添有效选择，国产首仿TAS-102（苏远®） “飞入寻常百姓家”</title>
    <updated>2021-01-21T19:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/A8_WM3n356Tu3pYVCF4rQg</id>
    <link href="https://mp.weixin.qq.com/s/A8_WM3n356Tu3pYVCF4rQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【说文解泌】多线守护，长期生存！晚期肾癌免疫治疗突破之路</title>
    <updated>2021-01-21T19:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/CA0as1Dn2zrvunBCHy3yjg</id>
    <link href="https://mp.weixin.qq.com/s/CA0as1Dn2zrvunBCHy3yjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BRAF+最前沿月评｜第一期 BRAF+MEK双靶连续剂量是BRAF突变黑色素瘤标准治疗方案</title>
    <updated>2021-01-21T19:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/2oCK5gA1SHXjf8ZI9URx4Q</id>
    <link href="https://mp.weixin.qq.com/s/2oCK5gA1SHXjf8ZI9URx4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【用“实例”说话】晚期肝癌伴黄疸，多措并举带来生存获益</title>
    <updated>2021-01-21T19:46:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/tUevRS56SIARU1U59DyeAw</id>
    <link href="https://mp.weixin.qq.com/s/tUevRS56SIARU1U59DyeAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2713】@所有人，「2020金研奖」十大原创研究人气投票开始！40选10由您决定！</title>
    <updated>2021-01-20T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/P8-L-kqn8La_Xk-r2SnEiA</id>
    <link href="https://mp.weixin.qq.com/s/P8-L-kqn8La_Xk-r2SnEiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2021 ASCO-GI】孙永琨教授对话依荷芭丽·迟教授：安罗替尼可显著改善RAS/BRAF野生型晚期结直肠癌患者的OS</title>
    <updated>2021-01-20T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/PMWOIsXIEjwVrHw73i2KxA</id>
    <link href="https://mp.weixin.qq.com/s/PMWOIsXIEjwVrHw73i2KxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人物专访｜百济神州吴清漪：肿瘤新药上市即 “红海”，营销需全渠道广覆盖</title>
    <updated>2021-01-20T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/UgCmTFdInjH4Lx67lugf9A</id>
    <link href="https://mp.weixin.qq.com/s/UgCmTFdInjH4Lx67lugf9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【年度巨制】2020肺癌年终盘点Session 1：风起云涌，花落谁家——早期、局晚期NSCLC研究进展（文末有惊喜）</title>
    <updated>2021-01-20T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/jC6moKMczC8lqV3YFHXaZg</id>
    <link href="https://mp.weixin.qq.com/s/jC6moKMczC8lqV3YFHXaZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年度巨制丨「骨与软组织肿瘤药物盘点」SESSION 6：软组织肉瘤的靶向治疗</title>
    <updated>2021-01-20T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/Q4Q-RLm9i_XcUbAyL3m_uw</id>
    <link href="https://mp.weixin.qq.com/s/Q4Q-RLm9i_XcUbAyL3m_uw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>毕锋教授：安可达上市后临床用药体验良好，打破生物类似药认知壁垒势在必行</title>
    <updated>2021-01-20T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/65R7TNI25x5EjspHe5X22g</id>
    <link href="https://mp.weixin.qq.com/s/65R7TNI25x5EjspHe5X22g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【Best of SABCS深圳】中外专家聚首，擘画乳癌进展——1月16日</title>
    <updated>2021-01-20T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/rt3_IlyaVz4GBU7Y3P6MWg</id>
    <link href="https://mp.weixin.qq.com/s/rt3_IlyaVz4GBU7Y3P6MWg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>男性每天多喝一杯咖啡，患前列腺癌的风险降低近1％</title>
    <updated>2021-01-20T19:28:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/Kwlv-G6S2KxHSflk-HD4Rw</id>
    <link href="https://mp.weixin.qq.com/s/Kwlv-G6S2KxHSflk-HD4Rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2712】【2021 ASCO-GI】肝胆胰/神经内分泌肿瘤4项口头报告，重磅研究一文速览！</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/mirRumvQH752xqhgWLyhsg</id>
    <link href="https://mp.weixin.qq.com/s/mirRumvQH752xqhgWLyhsg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【年度巨制】2020肿瘤资讯肺癌年终盘点即将重磅来袭！</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/cd5ud-Gx2H38EIKy5xeWKA</id>
    <link href="https://mp.weixin.qq.com/s/cd5ud-Gx2H38EIKy5xeWKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【Best of SABCS深圳】专家云集论道深圳，共话乳癌最新进展 —— 1月15日</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/qvaILcL2L3G3ihaaeIWZNA</id>
    <link href="https://mp.weixin.qq.com/s/qvaILcL2L3G3ihaaeIWZNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【专家采访】王洁教授：帕博利珠单抗（可瑞达）覆盖适应证广，疗效数据优异，慈善赠药计划切实为患者降低经济负担</title>
    <updated>2021-01-19T19:13:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/pPAC8nhZfCwRyIxP9OehPw</id>
    <link href="https://mp.weixin.qq.com/s/pPAC8nhZfCwRyIxP9OehPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>